Diabetes, Type I Clinical Trial
Official title:
12-Week, Multinational, Multicenter, Controlled, Open, 1:1 Randomized, Parallel Clinical Trial Comparing the Safety of HMR1964 and Insulin Aspart Used in Continuous Subcutaneous Insulin Infusion (CSII) in Subjects With Type 1 Diabetes Mellitus
The purpose of this study is to compare the safety of HMR 1964 and insulin aspart when used in external pumps with respect to catheter occlusions, GHb assessment, insulin doses, blood glucose parameters, hypoglycemic episodes, unexplained hyperglycemia, adverse events, laboratory data, and vital signs.
n/a
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT00328302 -
Diabetes Type 1, Treatment Study Atacand/Placebo After Kidney Biopsy
|
Phase 4 | |
| Completed |
NCT00541515 -
Closing the Loop Between Glucose Sensor and Insulin Pump-developing an Algorithm
|
N/A | |
| Completed |
NCT00810589 -
A Randomised, Single Centre, Double-Blind, Two-Period Crossover, Glucose Clamp Trial
|
Phase 1 | |
| Terminated |
NCT01129232 -
Diabetes Virus Detection Project, Intervention With GAD-alum
|
Phase 2 | |
| Recruiting |
NCT00804232 -
Childhood Diabetes
|
N/A | |
| Completed |
NCT00308308 -
Efficacy & Safety of Inhaled Insulin in Type 1 Diabetes
|
Phase 3 | |
| Completed |
NCT00654121 -
Prevention of Clinical Onset of Type 1 Diabetes in High Risk First Degree Relatives
|
Phase 2 | |
| Completed |
NCT01754259 -
Effects of Ranolazine on Coronary Flow Reserve in Symptomatic Diabetic Patients and CAD
|
Phase 3 |